术后宫颈癌IMRT计划质量标准化预演研究
日本临床肿瘤学组JCOG1402研究通过预演评估47家参与机构对术后高危宫颈癌IMRT的计划质量依从性,中央审查发现每份计划平均3至4处偏差,约50%与淋巴结和阴道残端CTV勾画相关,10家机构因勾画、PTV外扩或剂量分布不符合方案被要求重新提交计划。
要点
- 中央审查每份计划平均3–4处偏差,约50%涉及淋巴结和阴道残端CTV勾画。
- 阴道残端CTV勾画差异大于淋巴结CTV,Dice系数均值约0.54–0.60。
- 47家机构中10家因勾画、PTV外扩或剂量分布不符合方案需重新提交计划。
核心结论
- 术后宫颈癌IMRT预演显示勾画偏差显著,尤其阴道残端CTV,需标准化以减少机构间差异。
研究设计与样本
- JCOG1402多中心临床试验预演,制备2例匿名术后宫颈癌CT数据集发送至47家参与机构评估计划质量。
主要发现
- 中央审查每份治疗计划平均3和4处偏差,淋巴结和阴道残端CTV勾画偏差约占总偏差50%。
- 病例1淋巴结和阴道残端CTV的Dice系数均值±1σ分别为0.81±0.03和0.60±0.09。
- 病例2淋巴结和阴道残端CTV的Dice系数均值±1σ分别为0.81±0.04和0.54±0.14。
- 47家机构中10家因勾画、PTV外扩和所需剂量分布不符合JCOG1402方案被要求重新提交治疗计划。
关键数值与推荐
- JCOG1402方案要求勾画、PTV外扩和剂量分布符合方案规定,否则需重新提交计划。
临床怎么用
- 预演数据可用于指导勾画和计划设计,促进术后宫颈癌IMRT计划标准化。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The purpose of this study was to assess compliance with treatment planning in a dummy-run for a multicenter clinical trial involving patients with high-risk postoperative uterine cervical cancer using intensity-modulated radiation therapy (IMRT) (JCOG1402 trial). METHODS: For the dummy-run, we prepared a computed tomography dataset comprising two anonymized cases of post-hysterectomy cervical cancer. These were sent to the 47 participating institutions to assess institutional plan quality such as delineations and dose distributions. RESULTS: Central review showed 3 and 4 deviations per treatment plan on average. The deviations related to the nodal and vaginal cuff clinical target volume (CTV) delineation, which accounted for approximately 50% of the total deviations. The CTV vaginal cuff showed considerable differences in delineation compared with the nodal CTV. For the Dice similarity coefficient, case 1 showed a mean ± 1σ of 0.81 ± 0.03 and 0.60 ± 0.09 for the nodal and the CTV vaginal cuff, respectively, while these were 0.81 ± 0.04 and 0.54 ± 0.14, respectively, for case two. Of the 47 institutions, 10 were required to resubmit their treatment plan because the delineations, planning target volume margin, and required dose distributions were not in accordance with the JCOG1402 protocol. CONCLUSIONS: The dummy-run test in postoperative uterine cervical cancer demonstrated substantial deviations in the delineations, particularly for the CTV vaginal cuff. The analysis data could provide helpful information on delineation and planning, allowing standardization of IMRT planning for postoperative uterine cervical cancer. TRIAL REGISTRATION: Japanese Clinical Trial Registry #: UMIN000027017 at https://upload.umin.ac.jp/cgi-open-bin/ctr/ctr_view.cgi?recptno=R000030672;language=J.
引用
- Okamoto H, Murakami N, Isohashi F, et al. Dummy-run for standardizing plan quality of intensity-modulated radiotherapy for postoperative uterine cervical cancer: Japan Clinical Oncology Group study (JCOG1402). Radiat Oncol. 2019. PMID: 31358026. doi:10.1186/s13014-019-1340-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。